STAT+: Pharmalittle: FDA holds rare second meeting over an ALS drug; U.S. to expand distribution for monkeypox vaccine
Even with new data, FDA reviewers remain skeptical about an investigational drug for ALS that is getting a rare second chance before an advisory committee.
Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot
